Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

Cited by (1,001)

Items 101–200 of 1,001

1. Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
   David James Pinato, Alvin J. X. Lee, Federica Biello, Elia Seguí, Anna Carbó, Riccardo Bruna, Mark Bower, Gianpiero Rizzo, Sarah Benafif, Carme Carmona et al. · 2020 · Cancers
2. Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021
   Weiqiu Jin, Kaichen Huang, Zeyu Ding, Mengwei Zhang, Chongwu Li, Zheng Yuan, Ke Ma, Xiaodan Ye · 2025 · Biomarker Research
3. Is acupuncture effective in the treatment of COVID-19 related symptoms? Based on bioinformatics/network topology strategy
   Zhenzhen Han, Yang Zhang, Pengqian Wang, Qilin Tang, Kai Zhang · 2021 · Briefings in Bioinformatics
4. Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses
   Valérie Gounant, Valentine Marie Ferré, Ghassen Soussi, Charlotte Charpentier, Héloïse Flament, Nadhira Houhou‐Fidouh, Gilles Collin, Céline Namour, Sandra Assoun, Alexandra Bizot et al. · 2021 · Journal of Thoracic Oncology
5. Role of Selenium in Viral Infections with a Major Focus on SARS-CoV-2
   Sabrina Sales Martínez, Yongjun Huang, Leonardo Acuna, Eduardo E. Laverde, David Trujillo, Manuel Alejandro Barbieri, Javier A. Tamargo, Adriana L. Campa, Marianna K. Baum · 2021 · International Journal of Molecular Sciences
6. Comprehensive review of implications of COVID‐19 on clinical outcomes of cancer patients and management of solid tumors during the pandemic
   Ankit Madan, Joshua Siglin, Aleem I. Khan · 2020 · Cancer Medicine
7. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
   Aljosja Rogiers, Inês Pires da Silva, Chiara Tentori, Carlo Alberto Tondini, Joseph M. Grimes, Megan H. Trager, Sharon H. Nahm, Leyre Zubiri, Michael P. Manos, Peter J. Bowling et al. · 2021 · Journal for ImmunoTherapy of Cancer
8. Survey of the Impact of COVID-19 on Oncologists’ Decision Making in Cancer
   Yüksel Ürün, Syed A. Hussain, Ziad Bakouny, Daniel Castellano, Saadettin Kılıçkap, Gilberto Morgan, Rana R. McKay, Kevin Pels, Andrew Lachlan Schmidt, Deborah B. Doroshow et al. · 2020 · JCO Global Oncology
9. Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
   Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frélaut, Aurélien Noret, Audrey Bellesœur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat et al. · 2020 · JNCI Cancer Spectrum
10. Factors Associated With Cancer Treatment Delay Among Patients Diagnosed With COVID-19
    Samyukta Mullangi, Emeline Mariam Aviki, Yuan Chen, Mark E. Robson, Dawn L. Hershman · 2022 · JAMA Network Open
11. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
    Chris A. Brosey, Jerry H. Houl, Panagiotis Katsonis, L.P.F. Balapiti-Modarage, Shobanbabu Bommagani, Andy Arvai, Davide Moiani, Albino Bacolla, Todd M Link, Leslie S. Warden et al. · 2021 · Progress in Biophysics and Molecular Biology
12. Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies
    Ronit Gurion, Uri Rozovski, Gilad Itchaki, Anat Gafter‐Gvili, Chiya Leibovitch, Pia Raanani, Haim Ben‐Zvi, Moran Szwarcwort, Mor Taylor-Abigadol, Eldad J. Dann et al. · 2021 · Haematologica
13. In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain
    Inés Suárez‐García, Isabel Perales-Fraile, Andrés González García, Arturo Muñoz Blanco, Luís Manzano, M. Fabregate, Jesús Díez‐Manglano, Eva Fonseca Aizpuru, Francisco Arnalich, Alejandra García García et al. · 2021 · PLoS ONE
14. Targeting Tumor Heterogeneity with Neoantigen-Based Cancer Vaccines
    Saranya Pounraj, Shuxiong Chen, Linlin Ma, Roberta Mazzieri, Riccardo Dolcetti, Bernd H. A. Rehm · 2023 · Cancer Research
15. TERAVOLT: Thoracic Cancers International COVID-19 Collaboration
    Jennifer G. Whisenant, Annalisa Trama, Valter Torri, Alessandro De Toma, Giuseppe Viscardi, Alessio Cortellini, Olivier Alain Michielin, Fabrice Barlési, Anne‐Marie C. Dingemans, Jan P. van Meerbeeck et al. · 2020 · Cancer Cell
16. The Impact of COVID-19 on Vulnerable Populations and Implications for Children and Health Care Policy
    Robert Siegel, Peter J. Mallow · 2020 · Clinical Pediatrics
17. Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes
    Pritam Sadhukhan, M. Talha Ugurlu, Mohammad Obaidul Hoque · 2020 · Cancers
18. Impacts of COVID‐19 on caregivers of childhood cancer survivors
    Courtney E. Wimberly, Lisa Towry, Caroline V. Caudill, Emily E. Johnston, Kyle M. Walsh · 2021 · Pediatric Blood & Cancer
19. COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic
    Alvin J. X. Lee, Karin R. Purshouse · 2021 · British Journal of Cancer
20. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients
    Muhammad Umair Mushtaq, Moazzam Shahzad, Sibgha Gull Chaudhary, Mary Luder, Nausheen Ahmed, Haitham Abdelhakim, Rajat Bansal, Ramesh Balusu, Shaun DeJarnette, Clint L. Divine et al. · 2021 · Transplantation and Cellular Therapy
21. Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology
    Catherine Allison Stewart, Carl Michael Gay, Kavya Ramkumar, Kasey R. Cargill, Robert J. Cardnell, Monique B. Nilsson, Simon Heeke, Elizabeth M. Park, Samrat T. Kundu, Lixia Diao et al. · 2021 · Journal of Thoracic Oncology
22. Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients
    Magdalena Anna Benda, Beatrix Mutschlechner, Hanno Ulmer, Claudia Grabher, Luciano Severgnini, Andreas Volgger, Patrick Reimann, Theresia Lang, Michele Atzl, Minh Huynh et al. · 2021 · British Journal of Haematology
23. Depression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: Association with treatment delays
    Yildirim, Ozgen Ahmet, Poyraz, Kerem, Erdur, Erkan · 2021 · Quality of Life Research
24. A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
    Carlo Visco, Luigi Marcheselli, Roberto Mina, Marianna C. Sassone, Anna Guidetti, Domenico Penna, Chiara M. Cattaneo, Valentina Bonuomo, Alessandro Busca, Andrés J.M. Ferreri et al. · 2021 · Blood Advances
25. Dosing Regimens of Immune Checkpoint Inhibitors: Attempts at Lower Dose, Less Frequency, Shorter Course
    Mengjie Jiang, Yujie Hu, Gang Lin, Chao Chen · 2022 · Frontiers in Oncology
26. Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development
    David J Thomson, Sue Sun Yom, Hina Saeed, Issam El Naqa, Leslie Ballas, Søren Møller Bentzen, Samuel T. Chao, Ananya Choudhury, Charlotte Elizabeth Coles, Laura L. Dover et al. · 2020 · International Journal of Radiation Oncology*Biology*Physics
27. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan
    Shu Yazaki, Tatsuya Yoshida, Yuki Kojima, Shigehiro Yagishita, Hiroko Nakahama, Keiji Okinaka, Hiromichi Matsushita, Mika Shiotsuka, Osamu Kobayashi, Satoshi Iwata et al. · 2021 · JAMA Oncology
28. Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
    Ziad Bakouny, Chris Labaki, Punita Grover, Joy A. Awosika, Shuchi Gulati, Chih–Yuan Hsu, Saif I. Alimohamed, Babar Bashir, Stephanie A Berg, Mehmet Asım Bilen et al. · 2022 · JAMA Oncology
29. COVID-19 and immune checkpoint inhibitors: initial considerations
    Ryan Joseph Sullivan, Douglas Buckner Johnson, Brian I. Rini, Tomas G. Neilan, Christine Marie Lovly, Javid J. Moslehi, Kerry Lynn Reynolds · 2020 · Journal for ImmunoTherapy of Cancer
30. Determinants of COVID-19 Mortality in Patients With Cancer From a Community Oncology Practice in Brazil
    Bruno Lemos Ferrari, Carlos Gil Ferreira, Márcia Menezes, Pedro De Marchi, Jorge Canedo, Andréia Cristina de Melo, Alexandre Andrade dos Anjos Jacome, Tomás Reinert, Rafael Duarte Paes, Bárbara Sodré et al. · 2021 · JCO Global Oncology
31. The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection
    Allen W. Zhang, Sejal M. Morjaria, Anna Kaltsas, Tobias M. Hohl, Rekha Parameswaran, Dhruvkumar M. Patel, Wei Zhou, Jacqueline Predmore, Rocío Pérez-Johnston, Justin Jee et al. · 2021 · Clinical Infectious Diseases
32. Granulocyte‐colony stimulating factor in COVID ‐19: Is it stimulating more than just the bone marrow?
    Tamara Nawar, Sejal M. Morjaria, Anna Kaltsas, Dhruvkumar M. Patel, Rocío Pérez-Johnston, Anthony F. Daniyan, Sham Mailankody, Rekha Parameswaran · 2020 · American Journal of Hematology
33. The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future
    Christopher J. D. Wallis, James W.F. Catto, Antonio Finelli, Adam Glaser, John L. Gore, Stacy Loeb, Todd Matthew Morgan, Alicia Katherine Morgans, Nicolas Mottet, Richard David Neal et al. · 2020 · European Urology
34. Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2
    Antonio Marra, Daniele Generali, Paola Zagami, Valeria Cervoni, Sara Gandini, Sergio Venturini, Stefania Morganti, Rita Passerini, Roberto Orecchia, Giuseppe Curigliano · 2020 · Annals of Oncology
35. COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
    Erik Gaitzsch, Verena Passerini, Elham Khatamzas, Carolin Dorothea Strobl, Maximilian Muenchhoff, Clemens Scherer, Andreas Osterman, Michael Heide, Anna Reischer, Marion S. Subklewe et al. · 2021 · HemaSphere
36. Dual Challenge of Cancer and COVID-19: Impact on Health Care and Socioeconomic Systems in Asia Pacific
    Roselle B. De Guzman, Monica Malik · 2020 · JCO Global Oncology
37. In silico dynamics of COVID-19 phenotypes for optimizing clinical management
    Chrysovalantis Voutouri, Mohammad R. Nikmaneshi, Charles Corey Hardin, Ankit Bharat Patel, Ashish Verma, Melin Janardan Khandekar, Sayon Dutta, Triantafyllos Stylianopoulos, Lance L. Munn, Rakesh K. Jain · 2021 · Proceedings of the National Academy of Sciences
38. The effect of anticancer treatment on cancer patients with COVID‐19: A systematic review and meta‐analysis
    Hanqing Liu, Dan Yang, Xinyue Chen, Zhihong Sun, Yutong Zou, Chuang Chen, Shengrong Sun · 2020 · Cancer Medicine
39. Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology
    Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, Nadia Harbeck, Rupert Bartsch, Hans P. M. W. Wildiers, Vivianne C. G. Tjan‐Heijnen, Miguel Martı́n, Sylvie Rottey, Daniele Generali et al. · 2021 · JCO Global Oncology
40. Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
    David James Pinato, Lorenza Scotti, Alessandra Gennari, Emeline Colomba-Blameble, Saoirse Olivia Dolly, Angela Loizidou, John David Chester, Uma Mukherjee, Alberto Zambelli, Mark Bower et al. · 2021 · European Journal of Cancer
41. Elderly People in Covid-19 Outbreak
    Zeynep Altın · 2020 · The Anatolian Journal of General Medical Research
42. Supportive care in patients with cancer during the COVID-19 pandemic
    Matti Aapro, Gary H. Lyman, Carsten Bokemeyer, Bernardo Leon Rapoport, Nicola Mathieson, N. Koptelova, Paul Cornes, Ronald Anderson, Pere Gascón, Nicole M. Kuderer · 2021 · ESMO Open
43. State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses
    Juliet Meir, Muhammad Abbas Abid, Muhammad Bilal Abid · 2021 · Transplantation and Cellular Therapy
44. Rates of COVID-19–Related Outcomes in Cancer Compared With Noncancer Patients
    Lova Sun, Sanjna L. Surya, Anh N. Le, Heena Desai, Abigail G. Doucette, Peter Edward Gabriel, Marylyn DeRiggi Ritchie, Daniel James Rader, Ivan P. Maillard, Erin Mary Bange et al. · 2020 · JNCI Cancer Spectrum
45. Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
    Saptarshi Sinha, Chanakya Nath Kundu · 2021 · Medical Oncology
46. Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
    Evangelos Terpos, Pellegrino Musto, Monika Martha Engelhardt, Michel Delforge, Gordon Cook, Francesca Gay, Niels W.C.J. van de Donk, Ioannis Ntanasis‐Stathopoulos, Annette Juul Vangsted, Christoph Driessen et al. · 2023 · Leukemia
47. A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study
    Chao Liu, Li Li, Kehan Song, Zhiying Zhan, Yi Yao, Hongyun Gong, Yuan Chen, Qun Wang, Xiaorong Dong, Zhibin Xie et al. · 2020 · Journal for ImmunoTherapy of Cancer
48. Risk Factors Associated with the Severity of COVID-19
    Martono Martono, Fitri Fatmawati, Sri Mulyanti · 2023 · Malaysian Journal of Medical Sciences
49. The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer
    Samuel M. Rubinstein, John A. Steinharter, Jeremy Lyle Warner, Brian I. Rini, Solange Peters, Toni K. Choueiri · 2020 · Cancer Cell
50. SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients
    Gabrielle M. Haeusler, Roland A. Ammann, Fabianne Altruda de Moraes Costa Carlesse, Andreas H. Groll, Diana Averbuch, Elio Castagnola, Philipp Agyeman, Bob Phillips, Flavio Henrique Gilli, Солопова Галина Геннадьевна et al. · 2021 · European Journal of Cancer
51. The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study
    Gülçin Şahingöz Erdal, Özlem Polat, Gökmen Umut Erdem, Ramazan Korkusuz, Fehmi Hindilerden, Mesut Yılmaz, Kadriye Kart Yaşar, Nilgün Işıksaçan, Deniz Güncel Tural · 2021 · International Journal of Clinical Oncology
52. COVID-19 cohort on children with cancer: delay in treatment and increased frequency of deaths
    Ana Luiza Magalhães de Andrade Lima, Maria do Céu Diniz Borborema, Ana Paula Rodrigues Matos, Kaline Maria Maciel de Oliveira, Maria Júlia Gonçalves de Mello, Mecneide Mendes Lins · 2021 · Revista Brasileira de Saúde Materno Infantil
53. Comparison of Cancer Patients to Non-Cancer Patients among COVID-19 Inpatients at a National Level
    Alain Bernard, Jonathan Cottenet, Philippe Bonniaud, Lionel Piroth, Patrick Arveux, Pascale Tubert‐Bitter, Catherine Quantin · 2021 · Cancers
54. Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality
    Mary Flook, Charlotte Jackson, Eleftheria Vasileiou, Colin R Simpson, Marisa D. Muckian, Utkarsh Agrawal, Colin McCowan, Yifan Jia, Josie Murray, Lewis Duthie Ritchie et al. · 2021 · BMC Infectious Diseases
55. Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment
    Albert Grinshpun, Yakir Rottenberg, Iddo Z. Ben‐Dov, Esther Oiknine‐Djian, Dana G. Wolf, Luna Kadouri · 2021 · ESMO Open
56. Impaired Humoral Immunity Is Associated With Prolonged COVID-19 Despite Robust CD8 T-Cell Responses
    Olga Lyudovyk, Justin Y. Kim, David Augustus Qualls, Madeline A. Hwee, Ya-Hui Lin, Sawsan R. Boutemine, Yuval Elhanati, Alexander Solovyov, Melanie Douglas, Eunise Chen et al. · 2022 · Cancer Cell
57. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
    Michael R. Grever, Leslie Ann Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema Ali Bhat, James Stewart Blachly, Timothy G. Call, Matt Cross, Claire E. Dearden, Judit Demeter et al. · 2021 · Leukemia
58. Impact of COVID-19 on Canadian Medical Oncologists and Cancer Care: Canadian Association of Medical Oncologists Survey Report
    Sharlene Gill, D. Hao, Hal W. Hirte, Alexi Campbell, B. Colwell · 2020 · Current Oncology
59. Changing vulnerability for hurricane evacuation during a pandemic: Issues and anticipated responses in the early days of the COVID-19 pandemic
    Jennifer L. Whytlaw, N. Hutton, Juita-Elena (Wie) Yusuf, Tihara Richardson, Saige Hill, Taiwo Olanrewaju-Lasisi, Pamela Antwi-Nimarko, Eduardo Landaeta, Rafael Diaz · 2021 · International Journal of Disaster Risk Reduction
60. Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
    Carlota Gudiol, Xavier Durà-Miralles, Pilar Hernández-Jiménez, M. Martínez-Cutillas, Francesc Fernández‐Avilés, Marina Machado, Lourdes Vázquez, Pilar Martín‐Dávila, Nathalie De Castro, Edson Abdala et al. · 2021 · Journal of Infection
61. Oncology patients’ perceptions of and experiences with COVID-19
    Christine A. Miaskowski, S M Paul, Karin E. Snowberg, Maura Abbott, Hala T. Borno, Susan Marina Chang, Lee May Chen, Bevin Cohen, Bruce A. Cooper, Marilyn J. Hammer et al. · 2020 · Supportive Care in Cancer
62. Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
    Pataje G.S. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey Craig Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia Chiara Formenti, Chandan Guha, Dale J. Hu et al. · 2020 · Radiation Research
63. The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort
    Fangyuan Zhao, Tara Olive Henderson, Toni Marie Cipriano, Brenda L. Copley, Michelle Liu, Rahul Burra, Sondra H. Birch, Olufunmilayo Ibironke Olopade, Dezheng Huo · 2021 · Cancer
64. Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
    Andrés Chang, Akil Akhtar, Susanne L. Linderman, Lilin Lai, Victor Manuel Orellana-Noia, Rajesh Valanparambil, Hasan Ahmed, Veronika I. Zarnitsyna, Ashley A. McCook-Veal, Jeffrey M. Switchenko et al. · 2022 · Journal of Clinical Oncology
65. Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
    Petra Langerbeins, Barbara F. Eichhorst · 2021 · Acta Haematologica
66. The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis
    James J Clark, Dominic Edmund Dwyer, Nina Pinwill, Peter Clark, Peter Johnson, Allan K. Hackshaw · 2020 · The Lancet Oncology
67. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
    Anne‐Gaëlle Goubet, Agathe Dubuisson, Arthur Géraud, F.X. Danlos, Safae Aarab Terrisse, Carolina Alves Costa Silva, Damien Drubay, Lea Touri, Marion Picard, Marine Mazzenga et al. · 2021 · Cell Death and Differentiation
68. One‐year mortality and consequences of COVID ‐19 in cancer patients: A cohort study
    Chen Chai, Xiaojun Feng, Meixia Lü, Shoupeng Li, Kui Chen, Hongxiang Wang, Wendan Wang, Zhaoming Tang, Gang Cheng, Xiaoxiong Wu et al. · 2021 · IUBMB Life
69. Impact of COVID‐19 in hematopoietic stem cell transplant recipients: A systematic review and meta‐analysis
    Moazzam Shahzad, Sibgha Gull Chaudhary, Muhammad Usman Zafar, Maha Awaiz Hassan, Ali Hussain, Fatima Ali, Iqra Anwar, Mamoon Ahmed, Nausheen Ahmed, Sharad Khurana et al. · 2022 · Transplant Infectious Disease
70. Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study
    Lewis Au, Laura Amanda Boos, Anthony J. Swerdlow, Fiona Byrne, Scott T.C. Shepherd, Annika Fendler, Samra Turajlic · 2020 · Cell
71. Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data
    Robin Park, Sul A Lee, Seong Yoon Kim, Andréia Cristina de Melo, Anup Kasi · 2020 · Acta Oncologica
72. Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities
    Lu Wang, Yinan Sun, Ye Yuan, Qi Mei, Xianglin Yuan · 2020 · Aging
73. Immune checkpoint inhibition in COVID-19: risks and benefits
    Parmida Sadat Pezeshki, Nima Rezaei · 2021 · Expert Opinion on Biological Therapy
74. Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
    Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S. Heitmann, Marissa Lisa Dubbelaar, Andreas Peter, Sebastian Hörber, Jens Bauer, Jonas Rieth et al. · 2021 · Cancer Discovery
75. Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
    Einat Shmueli, Amit Itay, Ofer Margalit, Raanan Berger, Sharon Halperin, Menucha Jurkowicz, Einav Gal Levin, Itzchak Levy, Liraz Olmer, Gili Regev‐Yochay et al. · 2021 · European Journal of Cancer
76. Evaluation of Inequities in Cancer Treatment Delay or Discontinuation Following SARS-CoV-2 Infection
    Adana A. M. Llanos, Adiba Ashrafi, Nabarun Ghosh, Jennifer Tsui, Yong Lin, Angela J. Fong, Shridar Ganesan, Carolyn J. Heckman · 2023 · JAMA Network Open
77. Causal effects of COVID‐19 on cancer risk: A Mendelian randomization study
    Jia Li, Haocheng Bai, Hao Qiao, Chong Du, Peizhuo Yao, Yu Zhang, Yifan Cai, Yiwei Jia, Xinyu Wei, Chaofan Li et al. · 2023 · Journal of Medical Virology
78. Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic
    Kate Mason, Philip McHale, Andy Pennington, Gillian Maudsley, Jennifer Day, Ben Barr · 2021 · Frontiers in Public Health
79. The Impact of COVID-19 Pandemic in Children With Cancer: A Report From Saudi Arabia
    Mohammad Hamad Alshahrani, Ghaleb Elyamany, Qanita Sedick, Walid Ibrahim, Amal Farah Mohamed, Mohamed O. Othman, Nour Al Thibani, Omar Alsuhaibani, Mohamed Al amro, Ali Gharawi et al. · 2020 · Health Services Insights
80. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period
    Hiba Dagher, Anne‐Marie Chaftari, Ishwaria Mohan Subbiah, Alexandre Elias Malek, Ying Jiang, Peter Makram Lamie, Bruno Palma Granwehr, Teny Mathew John, Eduardo Yepez Guevara, Jovan Borjan et al. · 2023 · eLife
81. Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany
    Monika Martha Engelhardt, Khalid Shoumariyeh, Amelie Rösner, Gabriele Ihorst, Francesca Biavasco, Katharina Meckel, Ivana von Metzler, Sebastian Theurich, Holger Frithjof Hebart, Matthias Grube et al. · 2020 · Haematologica
82. Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studies
    Liu Yang, Huan Lu, Wei Wang, Qi Liu, Changju Zhu · 2020 · Expert Review of Anticancer Therapy
83. Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis
    Elisa María Dorantes-Acosta, Diana Ávila-Montiel, Miguel Klünder‐Klünder, Luis Juárez‐Villegas, Horacio Márquez-González · 2021 · Frontiers in Oncology
84. Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
    Elmira R. Vagapova, Timofey D. Lebedev, Vladimir Prassolov · 2021 · Scientific Reports
85. Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients
    Douglas A. Tremblay, Carina Seah, Thomas Schneider, Sheena Bhalla, Jonathan Feld, Leonard Naymagon, Bo Wang, Vaibhav G. Patel, Tomi Wei Jun, Thomas A. Jandl et al. · 2020 · Cancer Medicine
86. Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs
    Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, Sivan Agranat, Orna Schwartz, Ayelet Shai, Sharon Nordheimer, Shlomit Fenig, Yelena Shechtman, Ella Kozlener et al. · 2021 · Cancers
87. Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients
    Giulia Di Felice, Giovanni Visci, Federica Teglia, Marco Angelini, Paolo Boffetta · 2022 · eLife
88. The impact of COVID-19 on systemic anticancer treatment delivery in Scotland
    Mark A Baxter, John Michael Murphy, David Cameron, Judith Jordan, Christine Crearie, Christina Lilley, Azmat Sadozye, Mary Maclean, Peter S Hall, Angela Phillips et al. · 2021 · British Journal of Cancer
89. Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance
    Sheng‐Han Wang, Shiou‐Hwei Yeh, Pei‐Jer Chen · 2021 · Cancers
90. Perspectives from the Cancer and Aging Research Group: caring for the vulnerable older patient with cancer and their caregivers during the COVID-19 crisis in the United States
    Mohile, Supriya, Dumontier, Clark, Mian, Hira, Loh, Kah Poh, Williams, Grant R., Wildes, Tanya M., Boyd, Kevin, Ramsdale, Erika, Pyne, Sonia, Magnuson, Allison et al. · 2020 · Journal of Geriatric Oncology
91. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
    Gino M Dettorre, Saoirse Olivia Dolly, Angela Loizidou, John David Chester, Amanda M. Jackson, Uma Mukherjee, Alberto Zambelli, Mark Bower, Christopher C.T. Sng, Ramón Salazar et al. · 2021 · Journal for ImmunoTherapy of Cancer
92. Impact of the early phase of the COVID pandemic on cancer treatment delivery and the quality of cancer care: a scoping review and conceptual model
    Melanie Powis, Carissa Milley-Daigle, Saidah Hack, Shabbir M.H. Alibhai, Simron Singh, Monika Karolina Krzyzanowska · 2021 · International Journal for Quality in Health Care
93. Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer
    Xiaoyan Yin, Wanqi Zhu, Xiaoyong Tang, Guangjian Yang, Xianguang Zhao, Kaikai Zhao, Liyang Jiang, Xiaolin Li, Hong Zhao, Xin Wang et al. · 2024 · BMC Cancer
94. Research and Management of Rare Diseases in the COVID-19 Pandemic Era: Challenges and Countermeasures
    Sanjana Fatema Chowdhury, Syed Muktadir Al Sium, Saeed Anwar · 2021 · Frontiers in Public Health
95. Mortality in Cancer Patients With COVID-19 Who Are Admitted to an ICU or Who Have Severe COVID-19: A Systematic Review and Meta-Analysis
    Amogh Rajeev Nadkarni, Swapna C Vijayakumaran, Sudeep Gupta, Jigeeshu Vasishtha Divatia · 2021 · JCO Global Oncology
96. Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies
    Silvia Ferrari, Chiara Caprioli, Alessandra Weber, Alessandro Rambaldi, Federico Lussana · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
97. Initial Report on Spanish Pediatric Oncologic, Hematologic and Post Stem Cell Transplantation Patients During SARS-CoV-2 Pandemic
    Anna Faura, Susana Rives, Álvaro Lassaletta, Elena Sebastián, Luís Madero, Jorge Huerta Aragonés, Marina García‐Morín, Antonio Pérez Martínez, Luisa Sisinni, Itziar Astigarraga et al. · 2020 · Pediatric Blood & Cancer
98. Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
    Nicola Giesen, Rosanne Sprute, Maria Madeleine Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, Catherina Lueck, Michael Koldehoff, Marcus Hentrich, Michael Sandherr et al. · 2020 · European Journal of Cancer
99. Which type of cancer patients are more susceptible to the SARS-COX-2: Evidence from a meta-analysis and bioinformatics analysis
    Bolin Wang, Yan Huang · 2020 · Critical Reviews in Oncology/Hematology
100. COVID‐19 and implications for dermatological and allergological diseases
     Timo Buhl, Stefan Beissert, Evelyn Gaffal, Matthias Goebeler, Michael Hertl, Cornelia Mauch, Kristian Reich, Enno Schmidt, Michael Peter Schön, Michael Sticherling et al. · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft